Does black seed oil work as a supplement?
Black seed oil has shown measurable effects on blood lipids, blood pressure and inflammatory markers in randomised research, but an official dosing recommendation is lacking and interactions with medications are a real point of concern. If you have cardiovascular problems or are taking medications, discuss it with your doctor first.
LDL cholesterol, total cholesterol and triglycerides fell significantly with black seed oil compared with placebo. This is shown by a meta-analysis of 34 randomised studies involving more than 2,200 participants. 'Good' HDL cholesterol, on the other hand, increased. The effect sizes are remarkably large, which sometimes points to publication bias or substantial differences between the individual studies. That is a reason to read the numbers with some caution, but the pattern is consistent.
For blood pressure, a meta-analysis of 82 randomised studies (more than 5,000 participants) showed significant reductions in both systolic and diastolic pressure. That same analysis also found reductions in inflammatory markers such as CRP and TNF-alpha. Whether those laboratory improvements also translate into fewer heart attacks or a longer lifespan cannot be demonstrated from this research. Doses in the studies ranged from 200 to 4,600 mg per day, and duration from 1 to 48 weeks, so a practical dosing recommendation does not yet exist.
For body weight, a modest but statistically significant reduction of an average of 1.8 kg and a small decrease in BMI were found across 13 randomised studies with 875 participants. The effect on waist circumference was not significant. Outcomes varied considerably between studies, so this effect is certainly not equally evident for everyone.
For blood sugar regulation in diabetes, there are indications that black seed improves fasting blood sugar and HbA1c (the measure of blood sugar control over a longer period). A more recent meta-analysis confirms this in humans. However, as a standalone treatment the evidence is too thin for clinical recommendations. Earlier reviews were largely based on animal research.
Safety and practical application remain points of attention. Reviews describe black seed as relatively safe across a broad dose range, but also warn of possible interactions with medications and of large variation in the composition of products on the market. Official clinical guidelines for its use do not yet exist.
Evidence is based on multiple meta-analyses and systematic reviews of randomised studies. The largest meta-analysis covers 82 RCTs and more than 5,000 participants. Limitations include large heterogeneity (I2 up to 97.8%), varying doses and product compositions, and possible publication bias at large effect sizes.